» Articles » PMID: 34359596

Lobular Breast Cancer: Histomorphology and Different Concepts of a Special Spectrum of Tumors

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2021 Aug 7
PMID 34359596
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Invasive lobular breast cancer (ILC) is the most common special histological type of breast cancer (BC). This review recapitulates developments in the histomorphologic assessment of ILC from its beginnings with the seminal work of Foote and Stewart, which was published in 1941, until today. We discuss different concepts of ILC and their implications. These concepts include (i) BC arising from mammary lobules, (ii) BC growing in dissociated cells and single files, and (iii) BC defined as a morpho-molecular spectrum of tumors with distinct histological and molecular characteristics related to impaired cell adhesion. This review also provides a comprehensive overview of ILC variants, their histomorphology, and differential diagnosis. Furthermore, this review highlights recent advances which have contributed to a better understanding of the histomorphology of ILC, such as the role of the basal lamina component laminin, the molecular specificities of triple-negative ILC, and E-cadherin to P-cadherin expression switching as the molecular determinant of tubular elements in -deficient ILC. Last but not least, we provide a detailed account of the tumor microenvironment in ILC, including tumor infiltrating lymphocyte (TIL) levels, which are comparatively low in ILC compared to other BCs, but correlate with clinical outcome. The distinct histomorphology of ILC clearly reflects a special tumor biology. In the clinic, special treatment strategies have been established for triple-negative, HER2-positive, and ER-positive BC. Treatment specialization for patients diagnosed with ILC is just in its beginnings. Accordingly, ILC deserves greater attention as a special tumor entity in BC diagnostics, patient care, and cancer research.

Citing Articles

Unraveling complexity and leveraging opportunities in uncommon breast cancer subtypes.

Pareja F, Bhargava R, Borges V, Brogi E, Canas Marques R, Cardoso F NPJ Breast Cancer. 2025; 11(1):6.

PMID: 39856067 PMC: 11760369. DOI: 10.1038/s41523-025-00719-w.


Mutations Matter: Unravelling the Genetic Blueprint of Invasive Lobular Carcinoma for Progression Insights and Treatment Strategies.

Kontogiannis A, Karaviti E, Karaviti D, Lanitis S, Gomatou G, Syrigos N Cancers (Basel). 2024; 16(22).

PMID: 39594781 PMC: 11593237. DOI: 10.3390/cancers16223826.


Glutamate Transport Proteins and Metabolic Enzymes are Poor Prognostic Factors in Invasive Lobular Carcinoma.

Young T, Bahnassy S, Abalum T, Pope E, Rivera A, Fernandez A bioRxiv. 2024; .

PMID: 39464069 PMC: 11507668. DOI: 10.1101/2024.09.29.615681.


Nomograms to predict the long-term prognosis for non-metastatic invasive lobular breast carcinoma: a population-based study.

Guan Y, Huang S, Yu B Sci Rep. 2024; 14(1):19477.

PMID: 39174612 PMC: 11341842. DOI: 10.1038/s41598-024-68931-5.


E-cadherin staining in the diagnosis of lobular versus ductal neoplasms of the breast: the emperor has no clothes.

Taha S, Boulos F Histopathology. 2024; 86(3):327-340.

PMID: 39138705 PMC: 11707503. DOI: 10.1111/his.15295.


References
1.
Ercan C, van Diest P, van der Ende B, Hinrichs J, Bult P, Buerger H . p53 mutations in classic and pleomorphic invasive lobular carcinoma of the breast. Cell Oncol (Dordr). 2012; 35(2):111-8. PMC: 3306558. DOI: 10.1007/s13402-012-0071-y. View

2.
Cutuli B, De Lafontan B, Kirova Y, Auvray H, Tallet A, Avigdor S . Lobular carcinoma in situ (LCIS) of the breast: is long-term outcome similar to ductal carcinoma in situ (DCIS)? Analysis of 200 cases. Radiat Oncol. 2015; 10:110. PMC: 4428244. DOI: 10.1186/s13014-015-0379-7. View

3.
Derksen P, Liu X, Saridin F, van der Gulden H, Zevenhoven J, Evers B . Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell. 2006; 10(5):437-49. DOI: 10.1016/j.ccr.2006.09.013. View

4.
Eusebi V, Betts C, Haagensen Jr D, Gugliotta P, Bussolati G, AZZOPARDI J . Apocrine differentiation in lobular carcinoma of the breast: a morphologic, immunologic, and ultrastructural study. Hum Pathol. 1984; 15(2):134-40. DOI: 10.1016/s0046-8177(84)80053-2. View

5.
Carbognin L, Sperduti I, Fabi A, Dieci M, Kadrija D, Griguolo G . Prognostic impact of proliferation for resected early stage 'pure' invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validation. Breast. 2017; 35:21-26. DOI: 10.1016/j.breast.2017.06.005. View